• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation.供者特异性抗 HLA 抗体与匹配的无关供者造血干细胞移植中的移植物失功。
Blood. 2011 Nov 24;118(22):5957-64. doi: 10.1182/blood-2011-06-362111. Epub 2011 Oct 3.
2
Donor-Specific HLA Antibodies Are Associated with Graft Failure and Delayed Hematologic Recovery after Unrelated Donor Hematopoietic Cell Transplantation.供者特异性 HLA 抗体与无关供者造血细胞移植后移植物失败和血液学恢复延迟有关。
Transplant Cell Ther. 2023 Aug;29(8):493.e1-493.e10. doi: 10.1016/j.jtct.2023.05.014. Epub 2023 May 21.
3
The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure.在接受非亲缘造血细胞移植的受者中检测到供者特异性 HLA 同种抗体可预测移植物失败。
Blood. 2010 Apr 1;115(13):2704-8. doi: 10.1182/blood-2009-09-244525. Epub 2010 Jan 20.
4
The association of de novo anti-HLA-DPB1 donor-specific antibody formation and primary graft failure after allogeneic hematopoietic cell transplantation.异基因造血细胞移植后新生抗HLA-DPB1供者特异性抗体形成与原发性移植物失败的关联。
Hum Immunol. 2018 Dec;79(12):861-864. doi: 10.1016/j.humimm.2018.08.009. Epub 2018 Aug 22.
5
HLA donor-specific antibodies in allogeneic hematopoietic stem cell transplantation: challenges and opportunities.同种异体造血干细胞移植中的 HLA 供者特异性抗体:挑战与机遇。
Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):645-650. doi: 10.1182/asheducation-2017.1.645.
6
Combination treatment of rituximab and donor platelets infusion to reduce donor-specific anti-HLA antibodies for stem cells engraftment in haploidentical transplantation.利妥昔单抗联合供者血小板输注降低供者特异性抗 HLA 抗体以促进单倍体相合移植中干细胞植入。
J Clin Lab Anal. 2020 Jul;34(7):e23261. doi: 10.1002/jcla.23261. Epub 2020 Feb 28.
7
Impact of donor-specific anti-HLA antibodies on graft failure and survival after reduced intensity conditioning-unrelated cord blood transplantation: a Eurocord, Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI) and Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) analysis.供者特异性抗 HLA 抗体对非亲缘性脐血移植后移植物失败和存活的影响:Eurocord、法国组织相容性和免疫遗传学学会(SFHI)和法国骨髓和细胞治疗移植学会(SFGM-TC)的分析。
Haematologica. 2013 Jul;98(7):1154-60. doi: 10.3324/haematol.2012.077685. Epub 2012 Dec 14.
8
Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation.补体结合供者特异性抗人白细胞抗原抗体与造血干细胞移植中原发性移植物功能衰竭的风险
Biol Blood Marrow Transplant. 2015 Aug;21(8):1392-8. doi: 10.1016/j.bbmt.2015.05.001. Epub 2015 May 15.
9
The Role of HLA Antibodies in HLA Mismatched Allogeneic Hematopoietic Stem Cell Transplantation.HLA抗体在HLA错配异基因造血干细胞移植中的作用
Clin Transpl. 2014:245-50.
10
Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets.供者特异性抗人白细胞抗原抗体与未处理的单倍体相合造血干细胞移植后的原发性移植物功能衰竭相关:一项采用随机分配训练集和验证集的前瞻性研究。
J Hematol Oncol. 2015 Jul 10;8:84. doi: 10.1186/s13045-015-0182-9.

引用本文的文献

1
Replacements at Structural or Functional Dimorphisms 103, 109 and 167 Distinguish HLA Class I Serologically Defined Antigens.结构或功能二态性处的替换103、109和167区分了血清学定义的HLA I类抗原。
HLA. 2025 Sep;106(3):e70387. doi: 10.1111/tan.70387.
2
Donor-specific anti-HLA antibodies (DSAs) in patients undergoing allogeneic hematopoietic stem cell transplantation from mismatched donors on behalf of GITMO and AIBT.代表全球免疫肿瘤学和血液免疫生物学试验协会,对接受来自不匹配供体的异基因造血干细胞移植患者的供体特异性抗人白细胞抗原抗体(DSAs)进行研究。
Blood Transfus. 2025 Mar;23(2):176-185. doi: 10.2450/BloodTransfus.790. Epub 2025 Jan 28.
3
The impact of donor-specific antibodies' presence on the outcome post-allogeneic hematopoietic stem cell transplantation: a survey from a single center.供者特异性抗体的存在对异基因造血干细胞移植后结局的影响:来自单一中心的调查
Front Oncol. 2024 Aug 21;14:1387181. doi: 10.3389/fonc.2024.1387181. eCollection 2024.
4
Desensitization Strategies for Donor-Specific Antibodies in HLA-Mismatched Stem Cell Transplantation Recipients: What We Know and What We Do Not Know.HLA 不匹配干细胞移植受者中供者特异性抗体的脱敏策略:我们所知与未知
Oncol Ther. 2024 Sep;12(3):375-394. doi: 10.1007/s40487-024-00283-6. Epub 2024 Jun 15.
5
A Single Centre Experience of Effective Desensitization Strategy for Children with High Anti-HLA Donor-Specific Antibodies Undergoing Haploidentical Hematopoietic Stem Cell Transplantation.单中心对具有高抗人白细胞抗原供者特异性抗体的儿童进行单倍体造血干细胞移植时有效脱敏策略的经验。
Indian J Hematol Blood Transfus. 2024 Apr;40(2):335-339. doi: 10.1007/s12288-023-01661-2. Epub 2023 Jun 20.
6
Ageing on the impact of distribution about preformed anti-HLA and anti-MICA antibody specificities in recipients prior to initial HSCT from East China.中国东部地区初次异基因造血干细胞移植前受者中衰老对预先形成的抗HLA和抗MICA抗体特异性分布的影响
Immun Ageing. 2024 Feb 20;21(1):15. doi: 10.1186/s12979-024-00417-4.
7
HLA-DPB1 genotype variants predict DP molecule cell surface expression and DP donor specific antibody binding capacity.HLA-DPB1基因分型变体可预测DP分子的细胞表面表达及DP供体特异性抗体结合能力。
Front Immunol. 2024 Jan 11;14:1328533. doi: 10.3389/fimmu.2023.1328533. eCollection 2023.
8
Pretransplant Desensitization of Donor-Specific Anti-HLA Antibodies with Plasmapheresis and Immunoglobulin Produces Equivalent Outcomes to Patients with No Donor Specific Antibodies in Haploidentical Hematopoietic Cell Transplant.在单倍体造血细胞移植中,采用血浆置换和免疫球蛋白对供者特异性抗HLA抗体进行移植前脱敏治疗,其效果与无供者特异性抗体的患者相当。
Res Sq. 2024 Jan 8:rs.3.rs-3832106. doi: 10.21203/rs.3.rs-3832106/v1.
9
Targeted Radiation Delivery before Haploidentical HCT for High-risk Leukemia or MDS Patients Yields Long-term Survivors.单倍体相合造血干细胞移植前对高危白血病或骨髓增生异常综合征患者进行靶向放疗可产生长期存活者。
Clin Cancer Res. 2024 Jan 17;30(2):274-282. doi: 10.1158/1078-0432.CCR-23-1200.
10
Kinetics of neutrophil engraftment in allogeneic stem cell transplantation.异基因干细胞移植中中性粒细胞植入的动力学
Blood Cell Ther. 2019 Apr 1;2(2):22-30. doi: 10.31547/bct-2018-011. eCollection 2019 May 10.

本文引用的文献

1
The impact of anti-HLA antibodies on unrelated cord blood transplantations.抗 HLA 抗体对非亲缘脐带血移植的影响。
Blood. 2010 Oct 14;116(15):2839-46. doi: 10.1182/blood-2009-10-249219. Epub 2010 Jul 13.
2
The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure.在接受非亲缘造血细胞移植的受者中检测到供者特异性 HLA 同种抗体可预测移植物失败。
Blood. 2010 Apr 1;115(13):2704-8. doi: 10.1182/blood-2009-09-244525. Epub 2010 Jan 20.
3
High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation.抗 HLA 抗体患者行单倍体造血干细胞移植后移植物失功风险高。
Transplantation. 2009 Oct 27;88(8):1019-24. doi: 10.1097/TP.0b013e3181b9d710.
4
Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT.采用氟达拉滨、马法兰和噻替哌的低强度预处理方案用于接受单倍体相合造血干细胞移植的成年患者。
Bone Marrow Transplant. 2010 Mar;45(3):429-36. doi: 10.1038/bmt.2009.189. Epub 2009 Aug 10.
5
Two sequence dimorphisms of DPB1 define the immunodominant serologic epitopes of HLA-DP.DPB1的两个序列双态性定义了HLA-DP的免疫显性血清学表位。
Hum Immunol. 2009 Oct;70(10):836-43. doi: 10.1016/j.humimm.2009.07.011. Epub 2009 Jul 25.
6
High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.高分辨率的供受者人类白细胞抗原(HLA)配型有助于无关供者骨髓移植的成功。
Blood. 2007 Dec 15;110(13):4576-83. doi: 10.1182/blood-2007-06-097386. Epub 2007 Sep 4.
7
A high degree of HLA disparity arises from limited allelic diversity: analysis of 1775 unrelated bone marrow transplant donor-recipient pairs.高度的人类白细胞抗原(HLA)差异源于有限的等位基因多样性:对1775对无关骨髓移植供受者配对的分析
Hum Immunol. 2007 Jan;68(1):30-40. doi: 10.1016/j.humimm.2006.09.004. Epub 2006 Oct 25.
8
Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients.在同种致敏受体中,预先形成的抗体而非致敏的T细胞是骨髓移植的初始和主要障碍。
Blood. 2007 Feb 1;109(3):1307-15. doi: 10.1182/blood-2006-05-022772. Epub 2006 Oct 3.
9
Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipients.体液免疫是致敏受体中同种异体骨髓移植的主要障碍。
Blood. 2006 Nov 15;108(10):3611-9. doi: 10.1182/blood-2006-04-017467. Epub 2006 Aug 3.
10
Hematopoietic stem-cell transplantation.造血干细胞移植
N Engl J Med. 2006 Apr 27;354(17):1813-26. doi: 10.1056/NEJMra052638.

供者特异性抗 HLA 抗体与匹配的无关供者造血干细胞移植中的移植物失功。

Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation.

机构信息

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.

出版信息

Blood. 2011 Nov 24;118(22):5957-64. doi: 10.1182/blood-2011-06-362111. Epub 2011 Oct 3.

DOI:10.1182/blood-2011-06-362111
PMID:21967975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3761379/
Abstract

Anti-HLA donor-specific Abs (DSAs) have been reported to be associated with graft failure in mismatched hematopoietic stem cell transplantation; however, their role in the development of graft failure in matched unrelated donor (MUD) transplantation remains unclear. We hypothesize that DSAs against a mismatched HLA-DPB1 locus is associated with graft failure in this setting. The presence of anti-HLA Abs before transplantation was determined prospectively in 592 MUD transplantation recipients using mixed-screen beads in a solid-phase fluorescent assay. DSA identification was performed using single-Ag beads containing the corresponding donor's HLA-mismatched Ags. Anti-HLA Abs were detected in 116 patients (19.6%), including 20 patients (3.4%) with anti-DPB1 Abs. Overall, graft failure occurred in 19 of 592 patients (3.2%), including 16 of 584 (2.7%) patients without anti-HLA Abs compared with 3 of 8 (37.5%) patients with DSA (P = .0014). In multivariate analysis, DSAs were the only factor highly associated with graft failure (P = .0001; odds ratio = 21.3). Anti-HLA allosensitization was higher overall in women than in men (30.8% vs 12.1%; P < .0001) and higher in women with 1 (P = .008) and 2 or more pregnancies (P = .0003) than in men. We conclude that the presence of anti-DPB1 DSAs is associated with graft failure in MUD hematopoietic stem cell transplantation.

摘要

抗 HLA 供体特异性抗体(DSA)已被报道与不合型造血干细胞移植中的移植物失功有关;然而,其在匹配的无关供体(MUD)移植中导致移植物失功的作用仍不清楚。我们假设针对错配 HLA-DPB1 位点的 DSA 与此种情况下的移植物失功有关。在 592 例 MUD 移植受者中,使用固相荧光检测法中的混合珠,前瞻性地检测了移植前抗 HLA Abs 的存在情况。使用含有相应供体 HLA 错配抗原的单抗原珠进行 DSA 鉴定。在 116 例患者(19.6%)中检测到抗 HLA Abs,包括 20 例(3.4%)抗 DPB1 Abs 患者。总的来说,在 592 例患者中有 19 例(3.2%)发生移植物失功,其中 584 例无抗 HLA Abs 的患者中有 16 例(2.7%)发生移植物失功,而 8 例有 DSA 的患者中有 3 例(37.5%)发生移植物失功(P =.0014)。在多变量分析中,DSA 是唯一与移植物失功高度相关的因素(P =.0001;优势比=21.3)。总的来说,女性的抗 HLA 同种致敏率高于男性(30.8%比 12.1%;P<0.0001),且 1 次(P =.008)和 2 次或以上妊娠(P =.0003)的女性高于男性。我们得出结论,抗 DPB1 DSA 的存在与 MUD 造血干细胞移植中的移植物失功有关。